A Global Collaboration to Harmonize Guidelines for Clinical Management of Ritonavir-Boosted Nirmatrelvir DDIs | Alice K. Pau

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Saye Khoo | Tissue-Specific Pharmacology: How Clinically Important Is It

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Charles Flexner | Tissue-Specific Pharmacology: Knowledge and Knowledge Gaps

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Simon Portsmouth | Pharmacologic Data on New and Pipeline Drugs - Shionogi Inc.

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Alice Pau | A Global Collaboration to Harmonize Guidelines for Clinical Management of Ritonavir-Boosted Nirmatrelvir DDIs

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Elin Lindhagen | Harmonization of DDI Guidelines Among Different Regulatory Agencies: Challenges and Opportunities

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Catia Marzolini | Short Versus Extended Nirmatrelvir/R Treatment Course and Ensitrelvir: How Do DDIs Differ?

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Mike Emerson | Management of Antiplatelet/DOAC DDIS (Pk/PD) - in Context of HIV, HCV, COVID Antiviral Therapy

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Dario Cattaneo | Case Presentation - Complex DDI case

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Emma Rubenstein | A Year of CAB/RPV Use, What Have We Learned in the Real World

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023